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Abstract
Cocaine is a worldwide used drug and its abuse is associated with physical, psychiatric and social
problems. The mechanism by which cocaine causes neurological damage is very complex and
involves several neurotransmitter systems. For example, cocaine increases extracellular levels of
dopamine and free radicals, and modulates several transcription factors. NF-κB is a transcription
factor that regulates gene expression involved in cellular death. Our aim was to investigate the
toxicity and modulation of NF-κB activity by cocaine in PC 12 cells. Treatment with cocaine (1 mM)
for 24 hours induced DNA fragmentation, cellular membrane rupture and reduction of
mitochondrial activity. A decrease in Bcl-2 protein and mRNA levels, and an increase in caspase 3
activity and cleavage were also observed. In addition, cocaine (after 6 hours treatment) activated
the p50/p65 subunit of NF-κB complex and the pretreatment of the cells with SCH 23390, a D1
receptor antagonist, attenuated the NF-κB activation. Inhibition of NF-κB activity by using PDTC
and Sodium Salicilate increased cell death caused by cocaine. These results suggest that cocaine
induces cell death (apoptosis and necrosis) and activates NF-κB in PC12 cells. This activation
occurs, at least partially, due to activation of D1 receptors and seems to have an anti-apoptotic
effect on these cells.
Introduction
Cocaine is a drug of abuse with a prevalence of 2.8% in
USA and 0.3% worldwide. Cocaine is the second highest
drug of abuse in USA, according to the United Nations
Office on Drug and Crime (UNODC) (source: World
Drug Report, 2007; http://www.unodc.org/pdf/research/
wdr07/WDR_2007.pdf).
Cocaine inhibits dopamine transporter (DAT) in plasma
membrane causing an increase in extracellular dopamine
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levels. This results in the stimulation of the brain reward
pathway that can lead to the development of addiction
[1,2]. Addiction is a chronic relapsing disease [3] and its
treatment is the most expensive of the neuropsychiatric
disorders [4] mainly due to the costs of healthcare, pro-
ductivity loss and crime (Office of National Drug Control
Policy, 2004; United Nations Office on Drugs and Crime,
2007).
Along with addiction, cocaine can also induce neurologi-
cal impairment (deficits in cognition, motivation, insight
and attention), behavioral disinhibition, emotional insta-
bility, impulsiveness, and movement disorders [5,6].
Clinical and pre-clinical studies have demonstrated the
occurence of learning and memory impairment and
movement disorders in cocaine abusers, even after a long
period of drug withdrawal [7,8]. Although the cellular
mechanisms underlying this deficit have not been identi-
fied yet, several lines of investigation suggest that either
necrotic or apoptotic neuronal death may account for
drug-of-abuse-induced neurological impairment [9].
Necrotic cell death involves loss of membrane integrity
and selective permeability, whereas apoptotic cell death is
characterized by membrane blebbing, cell shrinkage and
chromatin condensation and fragmentation. The apop-
totic changes are often accompanied by caspase activation
and cytochrome c release into cytosol [10]. Members of
the Bcl-2 family of proteins (Bax, Bak, Bcl-XL, Bcl-2, and
others) regulate mitochondrial integrity and cytochrome c
release [11,12] and so are important determinants of cell
death or survival [13,14].
Cocaine neurotoxicity has been associated with induction
of apoptosis such as activation of caspase [15-19], loss of
mitochondrial potential, and cytochrome c release into
cytosol [16,18], and alteration of Bax/Bcl-2 ratio [19].
Cocaine-induced expression of immediate early genes (c-
fos, c-jun) and transcription factors (CREB) has been
reported by several authors [20-22] and it is suggested that
changes in gene transcription may contribute to the devel-
opment of adaptative responses induced by the use of
cocaine [23].
Nuclear factor-κB (NF-κB) is a transcription factor found
in a variety of cell types including neurons and microglia
[24]. NF-κB can be activated by pro-inflammatory stimuli,
such as pathogen-derived lipopolysaccharide (LPS),
cytokines (TNFα, IL-1β) and reactive oxygen species [25-
27]. NF-κB, comprised members of Rel/NF-κB family of
proteins, forming homo-and heterodimers through com-
bination of the p65 (or RelA), p50, p52, c-Rel or RelB sub-
units. It is constitutively expressed in the cytoplasm where
it is bound to IκB, a protein that masks the nuclear local-
ization signal of NF-κB thereby retaining it in the cyto-
plasm [28]. Inducers of NF-κB act through intracellular
signaling cascades that activate the IκB kinases (IKKs),
which phosphorylate two specific N-terminal serines of
IκBα resulting in IκBα polyubiquitination and degrada-
tion in the 26S proteasome [29]. When IκBα is degraded,
NF-κB migrates to the nucleus and modulates transcrip-
tion of target genes involved in cell death. To further
understand cocaine-induced neurotoxicity we tested
whether cocaine induces cell death (apoptosis and necro-
sis) and activates NF-κB in PC12 cells.
Methods
Reagents
Dulbecco's modified Eagle's medium (DMEM), bovine
serum, horse serum, trypsin, penicillin and streptomycin
were provided by Cultilab (Campinas, Brazil). Reagents
for SDS-PAGE and immunoblotting were purchased from
Bio-Rad Laboratories (Richmond, CA, USA). SCH23390
was from ToCris, Missouri, USA; PDTC and Sodium sali-
cilate were obtained from Sigma-Aldrich, St Loui, MO,
USA. γ-32P-ATP and poly dI-dC from Amersham Bio-
sciences (Uppsala, Sweden), the gel shift assay system kit
for NF-κB from Promega (Madison, WI, USA), and the
BioRad protein assay kit from BioRad (Hercules, CA,
USA). Routine reagents were from Sigma-Aldrich (St
Louis, MO, USA).
Preparation of PC12 cells
PC12 cells, a dopaminergic neuronal model, were main-
tained in DMEM supplemented with 5% heat inactivated
bovine serum, 10% horse serum, penicillin (100 units/
mL), streptomycin (25 units/mL). Confluent cultures
were washed with phosphate-buffered saline (PBS),
detached with 2.0 mM EDTA, centrifuged and subcultured
(7.104 cell/well) to poly L-lysine coated 6-well plates.
After 48 hours, the medium was replaced by a DMEM
without serum and cultured under different combinations
of time exposure periods and drug treatments.
Treatment of cells with cocaine and inhibitors
Cells were treated for the indicated incubation periods
with various concentrations of cocaine. Cells treated with
PBS was used as controls. The inhibitory agents were dis-
solved directly into the culture medium at the indicated
concentration 20 minutes before cocaine treatment: SCH
23390, a D1 receptor antagonist (10, 50 and 100 μM),
PDTC (Pyrrolidinedithiocarbamate; 5 and 10 μM) and
Sodium Salicilate (1 and 2 μM), inhibitors of NF-κB.
SCH23390, PDTC and Sodium Salicilate were dissolved
in PBS.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared as previously described
[30] with minor modifications. Briefly, cells were scraped
in cold PBS (supplemented with 2 μg/mL leupeptin, 2 μg/
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mL antipain and 0.5 mM PMSF) and centrifuged at 4°C
for 2 min at 13,000 g. Pellets were resuspended in lysis
buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM
KCl, 0.1 mM EDTA, 0.5 mM PMSF, 2 μg/mL leupeptin, 2
μg/mL antipain, 3 mM sodium ortovanadate, 30 mM
sodium fluoride, 20 mM sodium pyrophosphate) and
incubated on ice for 10 min. After the addition of NP-40
(to a final 0.5% concentration), samples were vigorously
mixed and centrifuged for 30 s at 13,000 g. Supernatants
were kept at -80°C for immunoblot analysis. Nuclei were
resuspended in extraction buffer (20 mM HEPES, pH 7.9,
25% glycerol, 1.5 mM MgCl2, 300 mM NaCl, 0.25 mM
EDTA, 0.5 mM PMSF, 2 μg/mL leupeptin, 2 μg/mL
antipain), incubated for 20 min on ice and centrifuged for
20 min at 13,000 g at 4°C. The remaining supernatants
containing nuclear proteins were stored at -80°C. Protein
concentration was determined using the BioRad protein
reagent. EMSA for NF-κB was performed using a gel shift
assay kit from Promega. NF-κB double-stranded consen-
sus oligonucleotide (5'-AGTTGAGGGGACTTTC-
CCAGGC-3') was end-labeled with γ-32P-ATP using T4
polynucleotide kinase. Unincorporated nucleotides were
removed by passing the reaction mixture through a Sepha-
dex G-25 spin column (Amersham-Pharmacia, Uppsala,
Sweden). Purified 32P-labeled probe (30,000 cpm) was
incubated in 20 μL with 5 μg nuclear extracts in a binding
reaction mixture containing 50 mM NaCl, 0.2 mM EDTA,
0.5 mM DTT, 4% glycerol, 10 mM Tris-HCl (pH 7.5) and
0.05 μg poly (dI-dC) for 30 min at room temperature.
DNA-protein complexes were separated by electrophore-
sis through a 6% non-denaturing acrylamide:bis-acryla-
mide (37.5:1) gel in 0.5× Tris-borate/EDTA (TBE) for 2 h
at 150 V. Gels were vacuum-dried, and analyzed by auto-
radiography. For competition experiments, NF-κB and
TFIID (5'-GCAGAGCATATAAGGTGAGGTAGGA-3') unla-
beled double-stranded consensus oligonucleotide was
included in 2-fold molar excess over the amount of 32P-
NF-κB probe in order to detect specific and non-specific
DNA-protein interactions, respectively. Unlabeled oligo-
nucleotides were added to the reaction mixture 20 min
before the radioactive probe. The composition of the
complexes was determined by supershift assays; antibod-
ies (1:10 dilution) against different NF-κB subunits (p50,
p65, p52 and c-Rel) were added before the incubation of
nuclear extracts with the labeled oligonucleotide. Autora-
diographs were quantified by ChemImager detection sys-
tem (Alpha-Innotech Corporation, USA).
Immunoblot analyses
Electrophoresis was performed using a Bio-Rad mini-Pro-
tean II apparatus. In brief, the proteins present in the
cytosolic (30 μg) fractions were size-separated in SDS-
PAGE (10% or 15% acrylamide). The proteins were blot-
ted onto a nitrocellulose membrane (Bio-Rad) and incu-
bated with the specific antibodies (cytocrome-c sc-7159
(1:500) (Santa Cruz Biotechnology, CA, USA); α-spectrin
MAB1522 (1:1000); IκB-α ab325 (1:250) Bax ab32503
(1:250), Bcl-2 ab7973 (1:250) (Abcam, Cambridge, MA,
USA); or caspase-3 AB1899 (1:500) (Chemicon, Temec-
ula, CA, USA). The Ponceau staining method was used to
determine the loading amount (Salinovich and Monte-
laro, 1986). Immunoblots were quantified as described
above. Proteins recognized by antibodies were revealed by
ECL technique, following the instructions of the manufac-
turer (Amersham, Piscataway, NJ, USA). To standardize
and quantify the immunoblots, a ChemImager detection
system (Alpha-Innotech Corporation, USA) was used. β-
actin antibody (sc-1616, Santa Cruz, CA, USA) was used
as an internal control. Results were expressed in relation
to the intensity of β-actin and as percentage of control
value.
Expression of Bax, Bcl-2 and BDNF
Total RNA was isolated using Trizol reagent and semi
quantitative reverse transcription-PCR (RT-PCR) amplifi-
cation was performed according to the instructions of the
manufacturer (Invitrogen, Grand Island, NY, EUA). The
primer sequences were: BDNF (304 bp), 5'-ATGCTCAG-
CAGTCAAGTGCC-3'(sense) and 5'-AGC CTTCCTTCGTG-
TAACCC-3'(antisense); Bax (271 bp), 5'-
TGAACTGGACAACAACATGGAGC-3'(sense) and 5'-
GGTCTTGGATCCAGACAAACAGC-3'(antisense); Bcl-2
(259 pb), 5'-GGAGGATTGTGGCCTTCTTTGAG-3' (sense)
and 5'-TATGCACCCAGAGTGATGCAGGC-3' (antisense);
GAPDH (258 pb), 5'-GCCAAGTATGATGACATCAA-
GAAG-3' (sense) and 5'-TCCAGGGGTTTCTTACTCCTT-
GGA-3' (antisense). The GAPDH was used for PCR
control. The PCR conditions consisted of 45 s at 94°C, dif-
ferent number of cycles and temperature depending on
the gene studied for 30 s (45 cycles, 55°C: BDNF; 28
cycles, 50°C: Bax; 40 cycles, 40°C: Bcl-2; 30 cycles, 50°C:
GAPDH) and a final extension at 72°C for 10 min. Gel
electrophoresis of the PCR product was performed using
an ethidium bromide-containing agarose gel (1.5%), and
resulting bands were visualized under UV light. The pho-
tographs were captured by VilberLourmat (Alpha-
Innotech Corporation, EUA), and the optical density of
the bands was determined using the ImageJ software.
Results were expressed in relation to the intensity of
GAPDH and as percentage of control value.
Assessment of apoptosis by flow cytometry
DNA fragmentation was analyzed by flow cytometry after
DNA staining with PI according to the method previously
described [31]). After the incubation period, PC12 cells
were removed from the dishes using trypsin/EDTA (2.5 g/
L), centrifuged at 1000 × g for 15 min at 4°C, and the pel-
let was gently resuspended in 300 μL hypotonic solution
containing 50 μg/mL PI, 0.1% sodium citrate, and 0.1%
Triton X-100. The cells were then incubated for 2 h at 4°C.
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Fluorescence was measured and analyzed using a FACS
Calibur flow cytometer (Becton Dickinson, San Juan, CA,
USA. Fluorescence was measured using the FL2 channel
(orange-red fluorescence = 585/42 nm). Ten thousand
events were analyzed per experiment. Cells with PI fluo-
rescence were then evaluated by using the Cell Quest soft-
ware (Becton Dickinson), and results were expressed as a
percentage of cells with DNA fragmentation in relation to
untreated control cultures.
MTT reduction and LDH release assay
Cell viability was estimated by the 3-[4,5-dimethylthia-
zol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) reduc-
tion assay [32]. After incubation of the cells with SCH
23390, PDTC, Sodium Salicilate and cocaine for 6 and 24
h, the culture medium was replaced by new one and MTT
(final concentration 0.5 mg/mL) was added to the cells.
The absorbance (570 nm) was measured after 30 min in a
multiwell plate reader (Bio-tek instruments). To measure
the release of lactate dehydrogenase (LDH) into the
medium a colorimetric LDH-cytotoxicity assay kit was
used (Roche Molecular BioChemicals, Indianapolis, IN,
EUA). The results were expressed as percentage of control
value at 490 nm determined after 15–20 min in a multi-
well plate reader.
Caspase 3 activity
To measure the effects of cocaine on caspase 3 activity
colorimetric assay kit (Chemicon, Temecula, CA, USA)
was used. After 6 hours of treatment with 1 mM cocaine
cells were scraped in cold PBS, centrifuged at 1500 g for 10
minutes, resuspended in lyses buffer (50 mM Tris HCl, pH
7.4; 1 mM EDTA, 10 mM EGTA and 10 μM PMSF) and
incubated for 10 minutes in ice. After centrifugation
(10,000 g for 5 minutes) the supernatant was separated
and incubated with 50 μL AC-DEVD-AMC (capase-3 sub-
strate) at 37°C for 2 hours. 7-methylcoumarin (AMC),
formed from the cleavage of the substrate by caspase 3,
was spectrophotomteric assay at 460 nm. Increase in cas-
pase activity was expressed as percentage of control values.
Data analysis
Results were expressed as mean ± S.E.M. of the indicated
number of experiments. Statistical comparisons were per-
formed by non-paired Student's t test and one-way
ANOVA followed by the Newman-Keuls test P < 0.05 was
considered as statistically significant. All statistics analyses
were performed using a Prism4 software package (Graph-
pad Software, San Diego, CA, USA).
Results
Cocaine caused a time and concentration dependent 
activation of NF-κB in PC12 cells
Nuclear extracts from cells treated with 1 mM cocaine for
6 hours presented three DNA/protein complexes indi-
cated by EMSA assay (Figure 1A). The complex 1 was dis-
placed by an excess of unlabeled NF-κB, but not by TFIID
double stranded oligonucleotide consensus sequence,
demonstrating the specificity of NF-κB/DNA binding
interaction of this complex (Figure 1B). Complexes 2 and
3 were not displaced by the unlabeled NF-κB and are not
considered to be associated to NF-κB family.
Supershift analysis indicated that the p65 subunit anti-
body shifted DNA/protein interactions found in complex
1. The p50 subunit antibody induced a partial decrease in
complex 1. In contrast, the antibodies against the p52 and
c-Rel subunits did not affect DNA-protein complex (Fig-
ure 1C). This suggests that p50/p65 heterodimers were
included in 32P-NF-κB/protein complex 1. Complexes 2
and 3 were not displaced by the antibodies confirming
that they are not related to NF-κB family. Because complex
1, mainly composed by p50/p65 heterodimers, was the
major DNA/protein complex altered by the treatments,
the term NF-κB was used to identify this complex.
PC12 cells were incubated for 6 hours with different con-
centrations of cocaine (0.05 – 2.0 mM) and nuclear pro-
teins were submitted to EMSA assay. Activation of NF-κB
by cocaine was concentration-dependent; starting at 0.25
mM and with maximum response at 1 mM (Figure 1D).
We also observed that the activation of NF-κB started after
3 hours of treatment and persisted until to 8 hours (Figure
1E), however, 24 hours latter (Figure 1F) there was no
activation of NF-κB. The concentration of 1 mM cocaine
and 6 hours of incubation were then used to evaluate
changes induced by cocaine on NF-kB pathway in PC12
cells.
Increase of IκB-α degradation caused after cocaine 
exposure
To confirm the activation of NF-κB by cocaine in PC12
cells the content of IκB-α in the cytoplasm of cells treated
with 1 mM cocaine for 6 hours was measured. A reduction
in IκB-α expression (Figures 1G and 1H) was observed,
confirming our previous data.
Involvement of the D1 receptor in the effects of cocaine-
induced NF-κB binding activity
As cocaine indirectly induces activation of D1 receptors,
the cells were pre-treated with a D1 antagonist, SCH
23390, twenty minutes before the exposure to cocaine (1
mM). SCH 23390, at all concentrations tested, partially
inhibited the activation of NF-κB by cocaine (Figure 2), as
concluded by a partial reduction in the quantification of
NF-κB band compared to cocaine treated cells alone.
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Cocaine exposure induced PC12 cell death
Three methods (FACS, MTT and LDH activity) were used
to evaluate PC12 cell death. All assays were performed
after 6 and 24 hours of incubation with 1 mM cocaine.
Flow cytometric analysis was used to evaluate the effects
of cocaine on DNA fragmentation in PC12 cells. The pro-
portion of apoptotic cells in cocaine-treated PC12 cells (1
mM, 24 hours) was approximately 25-fold greater than in
PC12 cells were treated with 1 mM cocaine (COC) or PBS for 6 hoursFigure 1
PC12 cells were treated with 1 mM cocaine (COC) or PBS for 6 hours. Nuclear extract (5 μg) was submitted to 
EMSA assay. (A) Positions of protein/DNA complexes observed are indicated by numbers. Localization of free probe is also 
indicated. (B) Competition studies in the absence or presence of unlabeled specific (NF-κB consensus sequence 2-fold molar in 
excess) or non-specific oligonucleotide (TFIID consensus sequence, 2-fold molar in excess), as indicated. (C) Supershift assays 
incubated in the absence or presence of 2 μL of antibodies (1:10 dilution) against p50, p65, c-Rel and p52 subunits, as indicated. 
Antibodies were added 20 min prior to addition of the radiolabeled NF-κB consensus oligonucleotide. The position of specific 
NF-κB/DNA binding complex p50/p65 (band 1) is indicated. NS represents no specific binding (bands 2 and 3). (D) Concentra-
tion response curve and time-course of NF-κB activation induced by COC in PC12 cells. Nuclear proteins (5 μg) were 
extracted from cells treated with different concentrations of cocaine: 0.5, 0.25,0.5, 0.75, 1, 2 mM or PBS for 6 hours (E) Differ-
ent time points of NF-κB activation: 1, 3, 6 and 8 hours with 1 mM of COC (panel B) or (F) 24 hours with 1 and 2 mM COC 
or PBS. The position of specific NF-κB/DNA binding complex (p50/p65 complex) is indicated. (G) Representative immunoblot 
expression of IκB-α in PC12 cells after incubation with COC (1 mM) or PBS for 6 hours. The densitometric analysis (% of con-
trol) of the IκB-α band complex represented in (G) is shown (H). β-Actin was used as internal control. Results are expressed 
as mean + S.E.M. from three individual experiments. * p < 0.05 vs PBS (Student's t-test).
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Influence of SCH23390 on NF-κB activation induced by cocaine in PC12 cellsFigure 2
Influence of SCH23390 on NF-κB activation induced by cocaine in PC12 cells. Cells treated with SCH23390 (10, 50, 
100 μM) 20 min prior to cocaine (COC) (1 mM) or PBS treatments were incubated for 6 hours and EMSA assay was per-
formed with the nuclear extract. Panel A represents autoradiography of the EMSA assay. The position of specific NF-κB/DNA 
binding complex p50/p65 is indicated. Bottom graphic (panel B) represents densitometric analysis of the p50/p65 bands pre-
sented in the top panel. Results are expressed as mean + S.E.M. from three individual experiments. * p < 0.05 vs PBS and # p < 
0.05 vs COC (one-way ANOVA followed by Newman-Keuls test).
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control cells (PBS-treated) (Figure 3). No change was
observed after 6 hours.
The MTT assay indicates changes in metabolic activity
associated to cell survival (cell viability). A decrease in
metabolic activity of PC12 cells treated with cocaine for
24 hours (Figure 4D) was observed as compared with con-
trols, indicative of overall decreased cell viability. No
change was observed after 6 hour treatment (Figure 4B).
LDH is released from cells as a result of loss of plasma
membrane integrity. Incubation with cocaine raised LDH
activity in the medium after 6 (Figure 4A) and 24 hours
(Figure 4C).
Antagonism of the D1 receptor did not change cell viability
The effects of SCH 23390 on cocaine-induced PC12 cell
death were evaluated by measuring MTT reduction and
LDH release to the incubation medium. The pre-treat-
ment of the cells with 10 μM SCH 23390 did not change
cell viability (Figure 4).
Inhibitors of NF-κB increased PC12 cell death caused by 
cocaine
We next determined whether PDTC or Sodium Salicilate
modulates cocaine-induced cell toxicity as assessed by
LDH and MTT assays. Sodium salicilate inhibits the IκB-α
degradation, preventing the translocation of NF-κB to the
nucleus (Koop and Ghosh, 1994), whereas PDTC directly
inhibits NF-κB. Both drugs partially decreased NF-κB acti-
vation by cocaine (data not shown). The decrease in PC12
cell viability induced by cocaine was more pronounced in
the presence of the NF-κB inhibitors (Figure 4D). No dif-
ference was seen in the LDH assay (Figures 4A and 4C).
Cocaine exposure increased the α-spectrin cleavage
Spectrin plays a key role to maintain cellular membrane
proprieties. Cocaine (1 mM) augmented α-spectrin frag-
mentation (150 e 120 kDa) after 6 hours incubation (Fig-
ures 5A, B and 5C). This fragmentation was not observed
in PBS-treated cells. Activation of calpain and/or caspase-
3 resulted in α-spectrin cleavage to 150 and 120 kDa frag-
ments by caspase and 150 and 145 kDa by calpain. An
increase in the 150 and 120 kDa fragments indicating that
caspase-3 plays an important role in cell death induced by
cocaine.
Cocaine activated caspase-3 in PC12 cells
Cocaine-induced α-spectrin fragmentation and other
reports suggesting that caspase-3 is the major protease in
apoptosis led us to verify whether caspase-3 activation
was involved in the induction of PC12 cells apoptosis by
cocaine. Caspase-3 activity was measured at 6 h, a critical
time point at which cocaine induced the highest NF-κB
activation. Cocaine increased caspase-3 activity as well as
protein cleavage (another index of caspase-3 activation)
in PC12 cells when compared to control (PBS-treated)
cells (Figures 5D, E and 5F).
Cocaine reduced Bcl-2 in PC12 cells
Cocaine exposure significantly reduced Bcl-2 mRNA and
protein levels after 6 hour exposure and the mRNA levels
were still lower after 24 hours. No changes in Bax mRNA
and protein levels were observed (Figure 6).
Cocaine transiently increased BDNF mRNA levels
Since BDNF (Brain Derived Neurotrophic Factor) is a neu-
rotrofin that participates in the neuronal protection and
its expression can be regulated by transcription factors
(such as NF-κB) the expression of this protein was inves-
tigated in PC12 cells after incubation with cocaine. We
observed an increase in BDNF mRNA levels after 6 hours
of treatment, which was not seen after a longer period (24
hours) of incubation (Figure 6F).
Discussion
Cocaine treatment induced PC 12 cell death by apoptosis
and necrosis. These effects were verified by mitochondrial
dysfunction, increase in LDH release, activation of caspase
3, decrease in Bcl-2 expression and increase in α-spectrin
cleavage. Cocaine treatment also activated the p50/p65
subunit of NF-κB in PC 12 cells after 6 hour partially due
to the activation of D1 dopamine receptor.
Cocaine concentrations used in this study were similar to
those previously employed by others in different cell types
[18,33-36]. A wide range of cocaine plasma levels (0.3 μM
to 1 mM) has been reported in subjects who use this drug
[34,37] being compatible with the concentration used in
this study.
Cocaine treatment activated NF-κB in PC12 cells in the
interval of 3–8 hours while cell death was more pro-
nounced after 24 hours only. Supershift assay analysis
indicated that cocaine increased the p50/p65 NF-κB com-
plex content. In agreement with our results, others
showed activation of NF-κB by cocaine in different mod-
els. Chronic administration of cocaine induced NF-κB
activation in nucleus accumbens of mice [38]. Cocaine-
induced NF-κB activation was also observed in macro-
phages [39], human brain endothelial cells [40], and in
PC12 cells [17]. Imam et al. [17] showed that 24 hours of
exposure to low concentrations of cocaine (5–500 μM)
caused an increase of NF-κB activity in PC12 cells and, in
agreement with our results, higher concentrations of this
drug did not show significant alteration of this transcrip-
tion factor after 24 hour treatment.
So, none of these studies investigated the mechanism of
cocaine-induced NF-κB activation. This is the first report
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Effect of cocaine (COC) (1 mM, 6 hours) on DNA fragmentation in PC12 CellsFigure 3
Effect of cocaine (COC) (1 mM, 6 hours) on DNA fragmentation in PC12 Cells. A flow cytometric analysis was con-
ducted after the cells had been incubated for 6 and 24 hours with cocaine. Results are expressed as mean + S.E.M. from three 
individual experiments. * p < 0.05 vs PBS (one-way ANOVA followed by Newman-Keuls test).
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that investigates the mechanism linking activation of NF-
κB and cell death induced by cocaine.
The involvement of dopaminergic receptors in the activa-
tion of this transcription factor by cocaine was also inves-
tigated in PC 12 cells. Pre-incubation with a D1
antagonist, SCH 23390, caused a partial reduction in
cocaine-induced NF-κB activation, suggesting the partici-
pation of these receptors in this process. Others have also
investigated the participation of dopamine receptors in
the activation of NF-κB. Dopamine D1 receptor raised the
expression of immediate early genes (such as, c-fos, c-jun,
junB and zif-268 [41]) that act as positive modulators of
transcription factors, including NF-κB [42-44].
Han and col. (2007) suggested that the increase in NF-κB
activity caused by dopamine occurs by its interaction with
D1 receptors leading to the activation of G protein,
increased levels of intracellular cyclic AMP and stimula-
tion of the phospholypase C/PKC pathway [45]. These
events would lead to the activation of MAP kinases, which
in turn could activate NF-κB. Yang et al. (2003) reported
that in human cervical carcinoma (HeLa) cells transiently
expressing human D2 receptors, dopamine-induced acti-
vation of NF-κB is mainly dependent upon c-Src activa-
tion [46]. These investigators also presented evidence that
the PI3K and the MEK-ERK pathways are involved in
dopamine-induced activation of NF-κB.
Dopamine readily oxidizes to form reactive oxygen spe-
cies (ROS), free radicals, and quinones, a process that can
occur either spontaneously in the presence of transition
metal ions [47] or via an enzyme catalyzed reaction [48].
Activation of dopamine receptor can also increase perox-
ide hydrogen (H2O2) formation by protein kinase C
(PKC), subsequently leading to activation of p38 MAPK
and JNK, that stimulate NF-κB activation as showed by
Lee et al. (2006) in mouse embryonic cells [49]. In the
neuronal cell line, NG108-15, the D2 receptor-induced
NF-κB activation depends upon the MEK-ERK pathway,
rather than p38 MAPK [50]. Therefore, multiple mecha-
nisms have been reported to be responsible for mediating
the effects of dopamine on NF-κB activation in different
cell types.
Effect of PDTC, Sodium Salicilate and SCH23390 on cocaine-Induced toxicity in PC12 Cells (A and C: LDH release assay; B and D: MTT reduction assay)Figure 4
Effect of PDTC, Sodium Salicilate and SCH23390 on cocaine-Induced toxicity in PC12 Cells (A and C: LDH 
release assay; B and D: MTT reduction assay). PC12 cells were pre-treated for 20 min with various concentrations of 
PDTC, Sodium Salicilate or SCH23390 prior to cocaine (1 mM, 6 hours) treatment. Cell viability was estimated by MTT reduc-
tion (570 nm) and LDH release (490 nm) assays. Results are expressed as mean + S.E.M. from three individual experiments. * p 
< 0.05 vs PBS and # p < 0.05 vs COC (cocaine) (one-way ANOVA followed by Newman-Keuls test)
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NF-kB is a transcription factor activated in response to cel-
lular stress that is involved in the regulation of apoptosis.
Depending on the cell type and the apoptotic agent, NF-
κB has been reported to mediate or prevent apoptosis
[51]. The cell death process induced by cocaine was initi-
ated at 6 hours being more pronounced after 24 hours of
exposure. We also observed that both necrosis and apop-
tosis are involved in the induction of cell death by cocaine
(A) Cocaine (COC) exposure increased α-spectrin (240 kDa) cleavage and (E) increased cleavage of caspase 3 in PC12 cellsFigure 5
(A) Cocaine (COC) exposure increased α-spectrin (240 kDa) cleavage and (E) increased cleavage of caspase 3 
in PC12 cells. Cell lysates were extracted from PBS and cocaine (1 mM, 6 hours) treated PC12 cells. Cell lysate protein con-
tent (30 μg) was loaded and run on a SDS-polyacrylamide gel and submitted to Immunoblot assay. The densitometric analysis 
(% of control) of the 150,120 kDa (cleaved product of spectrin) and caspase-3 cleaved product (17 kDa) band complexes rep-
resented in A and D are shown on B, C and F respectably. β-Actin was used as internal control. (D) COC exposure raised cas-
pase-3 activity and expression in PC12 cells. Cells were treated with 1 mM of COC for 6 hours. Cell lysates were analyzed for 
caspase-3 activity, using the caspase-3 substrate (Ac-DEVD-AMC). Results are expressed as mean + S.E.M. from three individ-
ual experiments; * p < 0.05 vs PBS (Student's t-test).
Molecular Brain 2009, 2:3 http://www.molecularbrain.com/content/2/1/3
Page 11 of 15
(page number not for citation purposes)
(A) Cocaine (COC) exposure decreased Bcl-2 protein expression in PC12 cellsFigure 6
(A) Cocaine (COC) exposure decreased Bcl-2 protein expression in PC12 cells. Cell lysates were extracted from 
PBS and COC (1 mM, 6 hours) treated PC12 cells. Cell lysate protein content (30 μg) was loaded and run on a SDS-polyacry-
lamide gel and submitted to Immunoblot assay. The densitometric analysis (% of control) of the Bax and Bcl-2 band complexes 
represented in (A) are shown (B and C). β-Actin was used as internal control. (D) Effect of incubation with COC (1 mM) for 6 
or 24 hours on levels of mRNA for Bax, Bcl-2 and BDNF in PC12 cells. Cocaine increased BDNF mRNA levels after 6 hours 
(G) and decreased Bcl-2 mRNA levels after 6 and 24 hours of cocaine treatment (F) as indicated by RT-PCR assays. No 
changes were observed for Bax mRNA levels after both 6 and 24 hours of cocaine treatment (E). Results are expressed as 
mean + S.E.M. from three individual experiments. * p < 0.05 vs PBS (one-way ANOVA followed by Newman-Keuls test).
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as observed by rupture of the cell membrane and DNA
fragmentation in agreement with finding by others
[17,19,52].
To further investigate the role of NF-κB in cocaine
induced-cytotoxicity NF-κB cell permeable inhibitors
were used. The inhibition of NF-κB significantly increased
the cell death promoted by cocaine treatment, suggesting
that this transcription factor plays a protective role in
cocaine treated PC12 cells. Lee and colleagues showed an
anti-apoptotic effect of NF-κB in PC12 cells death induced
by auto-oxidized dopamine [40]. High constitutive NF-κB
activity mediates resistance to oxidative stress in neuronal
cells [53] and, agents that inhibit NF-κB activation
induced apoptosis in response to several neurotoxins [54-
58].
Cocaine caused a reduction in anti-apoptotic Bcl-2 pro-
tein level but no change in pro-apoptotic Bax altering,
therefore, the Bax/Bcl-2 ratio, which triggers cellular apop-
tosis. The reduction of Bcl-2 levels after exposure to
cocaine has also been reported in fetal rat myocardial cells
[59]. However an increase in Bax levels was observed after
30 minutes and 1 hour of exposure to cocaine (1.5 μM) in
locus coerulus cells [36], whereas no change was found
herein. These results demonstrate that different concentra-
tions of cocaine and time of exposure can differently reg-
ulate the Bax/Bcl-2 ratio.
In addition, study of caspases, which are also important
regulators of apoptosis, revealed that exposure of PC12
cells to cocaine increased caspase-3 activity of and the
cleavage of caspase-3 precursors. Several studies have
reported the induction of caspase-3 by cocaine both in
vitro [16,18,36,60] and in vivo [15,61]. Cocaine also
caused α-spectrin cleavage in fragments that correspond
to the degradation mediated by caspase-3, suggesting that
calpain is not involved in the α-spectrin fragmentation
process induced by this drug [62]. This data, together with
the increase observed in the caspase-3 activity, suggest that
cocaine induced apoptosis in PC12 cell by caspase-3 acti-
vation.
An increase of BDNF mRNA levels was found after 6 hours
of treatment with cocaine only, indicating a transitory
augment of this neurotrophin. Le Foll and colleagues also
observed a transitory increase of BDNF mRNA levels in
frontal cortex of rats after a single injection of cocaine
[63]. BDNF regulates the differentiation and apoptosis of
neurons and glial cells [64], and the increase in BDNF
may be considered as a line of defense against the apopto-
sis process caused by cocaine in our model. In fact, the
increase in BDNF mRNA levels could be linked to the acti-
vation of NF-κB [65]. The protective role of NF-κB in
cocaine treatment of PC12 cells observed herein may be
associated to expression of anti-apoptotic genes, such as
BDNF. However the compensatory mechanisms to cell
death induced by cocaine were ineffective to abolish the
apoptosis process.
Conclusion
The exposure of PC12 cells to cocaine decreased the ratio
Bax/Bcl-2, reducing the levels of Bcl-2, and leading to acti-
vation of caspase-3 that can act as a modulator of the
apoptosis process observed after 24 hours of exposure to
the drug (Figure 7). Moreover, cocaine activated NF-κB
(p50/p65) in a concentration and time dependent man-
ner and this effect was partially mediated by D1 receptors.
The activation of this transcription factor may represent a
compensatory mechanism to limit cell death.
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